Skip to content

Secnidazole

Nitroimidazole Antimicrobial — ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: flagentyl, secnidazol, seknidazol, solosec

OfpFDA approvedATC J01RA07ATC P01AB07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Secnidazole is an ofp drug in the Nitroimidazole Antimicrobial class catalogued in DrugCentral. It was first approved by the FDA in 2017. DrugCentral lists 1 molecular target, including fabH. Recorded indications include Bacterial vaginosis, Giardiasis and Infection by Trichomonas.

  • Approval status: ofp (first approved 2017 by the FDA).
  • Drug class: Nitroimidazole Antimicrobial.
  • Molecular targets: fabH (1 listed in DrugCentral).
  • Indications: Bacterial vaginosis, Giardiasis and Infection by Trichomonas.
  • ATC code: J01RA07 (Combinations of antibacterials).
  • Molecular formula: C7H11N3O3; molecular weight 185.18 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Bacterial vaginosis
  • Giardiasis
  • Infection by Trichomonas

Mechanism & targets

Established pharmacologic classNitroimidazole Antimicrobial

Molecular targets (1)

TargetGeneActionActivity
3-oxoacyl-[acyl-carrier-protein] synthase 3fabHunknownIC50 4.55

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2017-09-15FDA—SYMBIOMIX THERAPEUTICS LLC

ATC classification

ATC codeTherapeutic hierarchy
J01RA07ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › COMBINATIONS OF ANTIBACTERIALS › Combinations of antibacterials
P01AB07ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES › Nitroimidazole derivatives

Chemical structure

Molecular formulaC7H11N3O3
Molecular weight185.18 g/mol
CAS number3366-95-8
InChIKeyKPQZUUQMTUIKBP-UHFFFAOYSA-N
PubChem CID71815
CC(O)CN1C(C)=NC=C1[N+]([O-])=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Secnidazole used for?

DrugCentral lists the following indications for Secnidazole: Bacterial vaginosis, Giardiasis and Infection by Trichomonas.

How does Secnidazole work?

Its molecular targets in DrugCentral include fabH.

When was Secnidazole first approved?

Secnidazole was first approved by the FDA in 2017.

What drug class does Secnidazole belong to?

Secnidazole is in the Nitroimidazole Antimicrobial class.

What is the chemical formula of Secnidazole?

Secnidazole has the molecular formula C7H11N3O3 and a molecular weight of 185.18 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval2017-09-15
AgencyFDA
Targets1
Indications3
FormulaC7H11N3O3
DrugCentral ID2427
Interactive profile